Harmony Biosciences Holdings, Inc. (HRMY)

NASDAQ: HRMY · Real-Time Price · USD

35.32

-0.48 (-1.34%)

At close: Jul 24, 2026, 4:00 PM EDT

35.32

0.00 (0.00%)

After-hours: Jul 24, 2026, 4:10 PM EDT

HRMY Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	899.11	868.45	714.73	582.02	437.86	305.44
Revenue Growth (YoY)	20.71%	21.51%	22.80%	32.93%	43.35%	91.21%
Cost of Revenue	210.86	198.34	156.82	121.24	83.48	55.52
Gross Profit	688.25	670.11	557.92	460.79	354.37	249.92
Selling, General & Admin	274.3	272.05	221.27	192.69	163.3	132.03
Research & Development	224.44	189.59	145.83	76.06	70.89	30.37
Total Operating Expenses	498.73	461.64	367.09	268.76	234.19	162.39
Operating Income	189.52	208.47	190.83	192.03	120.19	87.53
Interest Income	22.64	21.92	18.54	14.73	3.13	0.22
Interest Expense	-14.05	-14.65	-17.5	-23.76	-18.8	-24.19
Other Non-Operating Income (Expense)	-0.53	-0.68	-0.07	-9.61	0.17	-26.15
Total Non-Operating Income (Expense)	8.06	6.6	0.98	-18.63	-15.5	-50.12
Pretax Income	197.57	215.06	191.8	173.4	104.69	37.43
Provision for Income Taxes	51.96	56.38	46.31	44.54	-76.78	2.83
Net Income	145.62	158.69	145.49	128.85	181.47	34.6
Net Income to Common	145.62	158.69	145.49	128.85	181.47	34.6
Net Income Growth	-4.65%	9.07%	12.91%	-28.99%	424.52%	-
Shares Outstanding (Basic)	58	57	57	59	59	58
Shares Outstanding (Diluted)	59	59	58	60	61	59
Shares Change (YoY)	0.96%	1.17%	-4.15%	-1.19%	3.19%	119.09%
EPS (Basic)	2.52	2.76	2.56	2.17	3.07	0.60
EPS (Diluted)	2.48	2.71	2.51	2.13	2.97	0.58
EPS Growth	-5.34%	7.97%	17.84%	-28.28%	412.07%	-
Free Cash Flow	341.79	347.89	218.67	219.08	144.29	98.26
Free Cash Flow Growth	-1.75%	59.09%	-0.19%	51.82%	46.85%	-
Free Cash Flow Per Share	5.83	5.94	3.78	3.63	2.36	1.66
Gross Margin	76.55%	77.16%	78.06%	79.17%	80.93%	81.82%
Operating Margin	21.08%	24.00%	26.70%	32.99%	27.45%	28.66%
Profit Margin	16.20%	18.27%	20.36%	22.14%	41.44%	11.33%
FCF Margin	38.01%	40.06%	30.59%	37.64%	32.95%	32.17%
EBITDA	214.85	233.8	214.94	216.39	143.57	106.37
EBITDA Margin	23.90%	26.92%	30.07%	37.18%	32.79%	34.82%
EBIT	189.52	208.47	190.83	192.03	120.19	87.53
EBIT Margin	21.08%	24.00%	26.70%	32.99%	27.45%	28.66%
Effective Tax Rate	26.30%	26.21%	24.14%	25.69%	-73.35%	7.56%

SEC Filings: 10-K · 10-Q